Stuart Kane Represents Dexcom in Corporate Headquarters Lease Expansion

NEWPORT BEACH, Calif. - Nov. 3, 2014 - PRLog -- Stuart Kane LLP is pleased to announce the successful negotiation of a lease amendment to expand the corporate headquarters of its client, Dexcom, Inc. .  Stuart Kane partner Josh C. Grushkin served as real estate counsel to Dexcom in negotiating the amendment to Dexcom’s existing lease with Kilroy Realty, L.P.

Adding approximately 90,000 square feet at 6290 Sequence Drive in San Diego, Dexcom’s headquarters will ultimately expand to a total of approximately 218,815 square feet, spread over three buildings at 6130, 6290 and 6340 Sequence Drive.

With flexibility in mind for the expansion, Dexcom and Kilroy worked together to efficiently negotiate the complex transaction to amend the existing lease.   “The Dexcom and Kilroy teams worked quickly to achieve their respective goals for the deal, and also meet the aggressive timetable for the delivery of the new expansion space,” said Grushkin, counsel for Dexcom.  “It was a pleasure being able to help facilitate the physical growth of a dynamic company like Dexcom.”

Based in Newport Beach, California, Grushkin and Stuart Kane’s real estate group serve corporate real estate users such as Dexcom, as well as public and private companies in real property leasing, acquisition, disposition, financing, development, construction, management and exchange transactions throughout the United States.

Dexcom's brokers on the transaction were Darren Morgan and Greg Bisconti of Cushman & Wakefield.  Ray Gliner of Crosbie Gliner Schiffman Southard & Swanson LLP served as Kilroy’s legal counsel.

About Stuart Kane LLP

Founded in 2013, Stuart Kane LLP is law firm suited to a changing legal world —committed to delivering efficient, responsive, focused and specialized legal representation in the areas of real estate, employment and litigation. For more information about Stuart Kane, visit www.stuartkane.com.

About Dexcom, Inc.

Dexcom, Inc. develops and markets continuous glucose monitoring systems for use by diabetes patients, as well as blood glucose monitoring systems used by healthcare providers in hospital critical care settings. For more information about Dexcom, visit www.dexcom.com.